Not everyone takes these meds for that reason
The advent of a large market opportunity for peptides has meant that there is a great deal of investment in peptide drug discovery and how peptides interact with targets, says Matt Bio, Cambrexs chief scientific officer
Novo Nordisk says it will sell semaglutide at a price comparable to other drugs in its class, known as GLP-1 agonists
Gastric bypass can have a strong metabolic effect and may be considered for patients with type 2 diabetes, but the best option depends on the patients full medical history and should be discussed with a bariatric surgeon
By 48 weeks, these figures increased to 8.7%, 17.1%, 22.8%, and 24.2%, respectively, versus 2.1% for placebo